Robertson Stephens Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,520
Closed -$251K 667
2025
Q3
$251K Buy
+4,520
New +$265K 0.01% 477
2024
Q4
Sell
-4,352
Closed -$518K 614
2024
Q3
$518K Buy
4,352
+2,775
+176% +$370K 0.02% 405
2024
Q2
$225K Buy
+1,577
New +$209K 0.01% 461

Other funds holding NVO

Robertson Stephens Wealth Management's NVO Position: Q4 2025 in Review

Robertson Stephens Wealth Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,520 shares — an estimated $251K sold.

Robertson Stephens Wealth Management first reported a position in NVO in Q2 2024 and held it in 3 quarters. The position peaked at $518K in Q3 2024. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Robertson Stephens Wealth Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Robertson Stephens Wealth Management sold 4,520 Novo Nordisk shares in Q4 2025, an estimated $251K.
  • Robertson Stephens Wealth Management first reported a position in Novo Nordisk in Q2 2024 and held it in 3 quarters.
  • Robertson Stephens Wealth Management's Novo Nordisk position peaked at $518K in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Robertson Stephens Wealth Management's 13F filing for Q4 2025, filed 2 Feb 2026.